127 related articles for article (PubMed ID: 37397404)
1. Generalized morphea induced by the COVID-19 vaccine in a patient with chronic urticaria.
Alotaibi H; Alsalhi A; Albinhar T; Alshathry Y; Barakeh M
Dermatol Reports; 2023 Jun; 15(2):9632. PubMed ID: 37397404
[TBL] [Abstract][Full Text] [Related]
2. Bullous pemphigoid after second dose of mRNA- (Pfizer-BioNTech) Covid-19 vaccine: A case report.
Alshammari F; Abuzied Y; Korairi A; Alajlan M; Alzomia M; AlSheef M
Ann Med Surg (Lond); 2022 Mar; 75():103420. PubMed ID: 35251600
[TBL] [Abstract][Full Text] [Related]
3. Generalized Papulovesicular Eruption as a Side Effect of the Pfizer-BioNTech COVID-19 Vaccine.
Alamri A; Alghamdi Y; Alamri SJ; Althaqafi MK; AlQurashi W; Bader BA; Mohanna AT; Almahdi B
Cureus; 2022 Feb; 14(2):e22414. PubMed ID: 35371700
[TBL] [Abstract][Full Text] [Related]
4. Generalized morphea following the COVID vaccine: A series of two patients and a bibliographic review.
Antoñanzas J; Rodríguez-Garijo N; Estenaga Á; Morelló-Vicente A; España A; Aguado L
Dermatol Ther; 2022 Sep; 35(9):e15709. PubMed ID: 35811413
[TBL] [Abstract][Full Text] [Related]
5. Syncope With Sinus Arrest Following a Single Dose of a COVID-19 Vaccine.
Ghoweba M; Sabayon MD
Cureus; 2023 Jan; 15(1):e34309. PubMed ID: 36860236
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
7. Generalized morphea following COVID-19 vaccine: Case report and literature review.
Alhayaza R; Alhayaza G; Algarni A; Alhumidi A; AlHarithy R
Clin Case Rep; 2023 Apr; 11(4):e7133. PubMed ID: 37006851
[TBL] [Abstract][Full Text] [Related]
8. Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community.
Abukhalil AD; Shatat SS; Abushehadeh RR; Al-Shami N; Naseef HA; Rabba A
BMC Infect Dis; 2023 Jan; 23(1):5. PubMed ID: 36604613
[TBL] [Abstract][Full Text] [Related]
9. Qualitative Assessment of Early Adverse Effects of Pfizer-BioNTech and Sinopharm COVID-19 Vaccines by Telephone Interviews.
Abu-Halaweh S; Alqassieh R; Suleiman A; Al-Sabbagh MQ; AbuHalaweh M; AlKhader D; Abu-Nejem R; Nabulsi R; Al-Tamimi M; Alwreikat M; Alnouti M; Suleiman B; Yousef M; Jarbeh ME; Al-Shudifat AE; Alqassieh A; Bsisu I
Vaccines (Basel); 2021 Aug; 9(9):. PubMed ID: 34579187
[TBL] [Abstract][Full Text] [Related]
10. Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5-11 Years - United States, May 17-July 31, 2022.
Hause AM; Baggs J; Marquez P; Myers TR; Su JR; Hugueley B; Thompson D; Gee J; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(33):1047-1051. PubMed ID: 35980875
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Vaccine Safety in Children Aged 5-11 Years - United States, November 3-December 19, 2021.
Hause AM; Baggs J; Marquez P; Myers TR; Gee J; Su JR; Zhang B; Thompson D; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(5152):1755-1760. PubMed ID: 34968370
[TBL] [Abstract][Full Text] [Related]
12. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
13. [Comparative Analyses of IgA Antibody Response of Non-COVID-19 Infected People Over 60 Years Old Following CoronaVac and Pfizer-BioNTech COVID-19 Vaccination].
Yürüker Ö; Yetkin O; Güvenir M
Mikrobiyol Bul; 2023 Apr; 57(2):330-333. PubMed ID: 37067217
[TBL] [Abstract][Full Text] [Related]
14. Lichenoid cutaneous skin eruption and associated systemic inflammatory response following Pfizer-BioNTech mRNA COVID-19 vaccine administration.
Onn PY; Chang CL
Respirol Case Rep; 2021 Nov; 9(11):e0860. PubMed ID: 34631106
[TBL] [Abstract][Full Text] [Related]
15. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020.
;
MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297
[TBL] [Abstract][Full Text] [Related]
16. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022.
Hause AM; Baggs J; Marquez P; Abara WE; Olubajo B; Myers TR; Su JR; Thompson D; Gee J; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(9):347-351. PubMed ID: 35239637
[TBL] [Abstract][Full Text] [Related]
17. Adverse reactions to the first and second doses of Pfizer-BioNTech COVID-19 vaccine among healthcare workers.
Maruyama A; Sawa T; Teramukai S; Katoh N
J Infect Chemother; 2022 Jul; 28(7):934-942. PubMed ID: 35361536
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccination associated severe immune thrombocytopenia.
Shah SRA; Dolkar S; Mathew J; Vishnu P
Exp Hematol Oncol; 2021 Jul; 10(1):42. PubMed ID: 34266487
[TBL] [Abstract][Full Text] [Related]
19. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
Petruzzi M; Galleggiante S; Messina S; Della Vella F
BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
[TBL] [Abstract][Full Text] [Related]
20. Adverse Events with the Pfizer-BioNTech COVID-19 Vaccine among Korean Healthcare Workers.
Im JH; Kim E; Lee E; Seo Y; Lee Y; Jang Y; Yu S; Maeng Y; Park S; Park S; Kim J; Lee JS; Baek JH
Yonsei Med J; 2021 Dec; 62(12):1162-1168. PubMed ID: 34816647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]